Ligand Pharmaceuticals LGND Change in Income Taxes
Change in Income Taxes at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInIncomeTaxesReceivable.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's change in income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's change in income taxes?
- Ligand Pharmaceuticals (LGND) reported change in income taxes of -$695K in Q1 2026.
- How has Ligand Pharmaceuticals's change in income taxes changed year-over-year?
- Ligand Pharmaceuticals's change in income taxes decreased by 107.5% year-over-year, from -$335K to -$695K.
- What is the long-term trend for Ligand Pharmaceuticals's change in income taxes?
- Over 2 years (2021 to 2024), Ligand Pharmaceuticals's change in income taxes has grown at a -23.8% compound annual growth rate (CAGR), from $3.98M to -$2.31M.
- What does change in income taxes mean?
- Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.